123 related articles for article (PubMed ID: 12371135)
1. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease.
Tuccari G; Villari D; Giuffrè G; Simone A; Squadrito G; Raimondo G; Barresi G
Histol Histopathol; 2002 Oct; 17(4):1077-83. PubMed ID: 12371135
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease.
Yoshioka K; Kakumu S; Arao M; Tsutsumi Y; Inoue M; Wakita T; Ishikawa T; Mizokami M
J Clin Pathol; 1990 Apr; 43(4):298-302. PubMed ID: 1692847
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
[TBL] [Abstract][Full Text] [Related]
4. Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases.
Knoess M; Kurz AK; Goreva O; Bektas N; Breuhahn K; Odenthal M; Schirmacher P; Dienes HP; Bock CT; Zentgraf H; zur Hausen A
World J Gastroenterol; 2006 Sep; 12(36):5870-4. PubMed ID: 17007055
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions.
Tuccari G; Giuffrè G; Scarf R; Simone A; Todaro P; Barresi G
Eur J Histochem; 2005; 49(1):33-8. PubMed ID: 15823792
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas.
Giuffrè G; Barresi V; Skliros C; Barresi G; Tuccari G
Oncol Rep; 2007 May; 17(5):1021-6. PubMed ID: 17390038
[TBL] [Abstract][Full Text] [Related]
8. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
[TBL] [Abstract][Full Text] [Related]
9. Expression of HBsAg and HBcAg in liver tissue: correlation with disease activity.
Nakopoulou L; Adraskelas N; Stefanaki K; Zacharoulis D; Hadziyannis S
Histol Histopathol; 1992 Jul; 7(3):493-9. PubMed ID: 1504471
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of lactoferrin in cartilage-forming neoplasms.
Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
J Orthop Sci; 2009 Nov; 14(6):732-7. PubMed ID: 19997820
[TBL] [Abstract][Full Text] [Related]
11. An ultrastructural study of six cases of chronic active C hepatitis. A comparison with chronic active B hepatitis.
Balercia G; Accordini C; Di Piramo D; Martella F; Tomezzoli A
Ultrastruct Pathol; 1993; 17(5):477-82. PubMed ID: 8256292
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis in multiple virus infection: histopathological evaluation.
Colombari R; Dhillon AP; Piazzola E; Tomezzoli AA; Angelini GP; Capra F; Tomba A; Scheuer PJ
Histopathology; 1993 Apr; 22(4):319-25. PubMed ID: 8514275
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
14. Histological behaviour of chronic hepatitis in patients treated with alpha interferon.
Villari D; Raimondo G; Freni MA; Rodinò G; Aiello A; Fava A; Longo G; Batolo D
Pathology; 1992 Oct; 24(4):243-6. PubMed ID: 1289764
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?
Andreone P; Cursaro C; Gasbarrini G
J Hepatol; 1993 Sep; 19(2):228-31. PubMed ID: 8301055
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis.
Ma X; Qiu DK; Peng YS
World J Gastroenterol; 2001 Apr; 7(2):238-42. PubMed ID: 11819767
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HBV and HCV antigens expression in correlation with HBV DNA and HCV RNA occurrence in liver biopsy specimens of patients with chronic hepatitis type B and chronic hepatitis type C, respectively.
Walewska-Zielecka B; Swiderska H; Jończyk M; Nowosławski A
Med Sci Monit; 2001 May; 7 Suppl 1():147-50. PubMed ID: 12211710
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructure of normal and hepatitis virus infected human and chimpanzee liver: similarities and differences.
Schaff Z; Eder G; Eder C; Lapis K
Acta Morphol Hung; 1992; 40(1-4):203-14. PubMed ID: 1365764
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD163 in the liver of patients with viral hepatitis.
Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
Pathol Res Pract; 2005; 201(5):379-84. PubMed ID: 16047947
[TBL] [Abstract][Full Text] [Related]
20. Methods for localization of hepatitis B surface antigen in liver tissue. An evaluation of different staining- and tissue preparation methods.
Clausen PP; Møller AM; Praetorius Clausen P; Mathiesen LR
Acta Pathol Microbiol Immunol Scand A; 1983 Sep; 91(5):329-34. PubMed ID: 6613583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
